iShares Neuroscience and Healthcare ETF Rating $35.40 +0.44 (+1.26%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsShort InterestBuy This Stock iShares Neuroscience and Healthcare ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBRN Aggregate RatingModerate Buy 2.82Holdings in IBRN have an aggregate rating of Moderate Buy based on 379 analyst ratings issued in the past year covering 23 companies (73.8% of the portfolio).IBRN Aggregate Price Target$35.40High Prediction$35.40Average Prediction$35.40Low Prediction$35.40Holdings in IBRN have an aggregate price target of $35.40 and a range of $35.40 to $35.40 covering 23 companies (73.8% of the portfolio).IBRN Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Neuroscience and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 IBRN Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.71%XENEXenon Pharmaceuticals$57.72+0.5%3.2031 of 5 stars3.00$73.13 26.7%18Upcoming Earnings4.44%ARWRArrowhead Pharmaceuticals$74.93-1.9%2.6253 of 5 stars2.83$84.20 12.4%12News CoverageUpcoming Earnings4.20%ALKSAlkermes$36.25+6.1%3.4679 of 5 stars2.82$44.29 22.2%17Trending NewsGap Up4.02%AXSMAxsome Therapeutics$223.06-0.3%3.1576 of 5 stars2.90$251.89 12.9%21Trending NewsEarnings ReportAnalyst ForecastInsider Trade3.93%CNTACentessa Pharmaceuticals$39.67-0.1%1.7723 of 5 stars2.21$40.70 2.6%143.90%ARGXargenex$794.70-2.0%4.1798 of 5 stars2.92$1,016.22 27.9%24Upcoming Earnings3.88%PTCTPTC Therapeutics$65.04-0.7%3.8059 of 5 stars2.63$84.40 29.8%16News CoverageUpcoming Earnings3.77%PRAXPraxis Precision Medicines$333.30-1.3%3.3917 of 5 stars3.00$590.78 77.3%20Positive News3.72%SRRKScholar Rock$47.13+1.4%3.4273 of 5 stars3.17$55.40 17.5%18Upcoming Earnings3.63%NBIXNeurocrine Biosciences$135.06+0.7%3.81 of 5 stars2.82$180.45 33.6%22Trending News3.63%BIIBBiogen$189.13+1.0%4.0892 of 5 stars2.50$214.23 13.3%28Earnings ReportAnalyst Upgrade3.54%ACADACADIA Pharmaceuticals$22.35+0.7%4.5205 of 5 stars2.75$31.21 39.6%20Upcoming Earnings3.45%DNTHDianthus Therapeutics$90.24+1.0%3.3289 of 5 stars3.00$115.55 28.0%14News CoverageEarnings Report3.22%CPRXCatalyst Pharmaceuticals$30.86+6.6%4.7636 of 5 stars3.50$34.00 10.2%6Upcoming Earnings2.92%DNLIDenali Therapeutics$18.92+1.3%3.0535 of 5 stars2.88$35.00 85.0%16News CoverageUpcoming Earnings2.91%SUPNSupernus Pharmaceuticals$49.19+1.2%3.5222 of 5 stars2.43$62.17 26.4%7News CoverageEarnings Report2.54%EWTXEdgewise Therapeutics$38.01+20.9%1.0436 of 5 stars2.89$38.13 0.3%9News CoverageUpcoming EarningsInsider TradeGap UpHigh Trading Volume2.53%DYNDyne Therapeutics$17.47-1.4%3.4454 of 5 stars2.94$35.14 101.2%17Analyst Downgrade2.15%SRPTSarepta Therapeutics$21.79-1.1%3.1881 of 5 stars2.11$32.63 49.7%28Upcoming Earnings2.01%AXGNAxoGen$43.74+2.6%1.4606 of 5 stars2.64$46.50 6.3%11Trending NewsEarnings ReportAnalyst DowngradeAnalyst Revision1.75%CAPRCapricor Therapeutics$32.96-1.6%2.166 of 5 stars2.80$46.09 39.8%10News CoverageUpcoming EarningsInsider Trade1.52%TSHATaysha Gene Therapies$6.94+4.5%2.7494 of 5 stars3.00$11.64 67.7%13Upcoming Earnings1.42%BHVNBiohaven$9.71-4.3%2.8952 of 5 stars2.78$22.47 131.4%18Trending NewsUpcoming EarningsAnalyst ForecastHigh Trading Volume This page (NYSEARCA:IBRN) was last updated on 5/5/2026 by MarketBeat.com Staff. From Our PartnersMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredThe $1.75T "Backdoor" ticker (NOT Starlink)When the SpaceX IPO launches, most investors will already be too late. The real opportunity isn't the IPO itse...Behind the Markets | SponsoredURGENT: $2 Gold Stock With Major DiscoveryA $2 gold stock is said to quietly control what may be the largest gold deposit in the world - worth nearly $1...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Neuroscience and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Neuroscience and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBRN Stock Alerts